Fenlean T31773
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Fenlean (FLZ) is currently conducting a phase I trial in the Institute of pharmacy, Chinese Academy of medical sciences as a potential treatment for Parkinson's disease.
CAS nr:
863193-70-8
Purity:
98%
Molecular Weight:
449,5
SMILES:
O=C(NCCC1=CC=C(O)C=C1)/C(C2=CC(OC)=CC=C2OC)=C/C3=CC=C(O)C(OC)=C3
Formula:
C26H27NO6
Pathway:
Target:
